Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 21830960)

1.

New options in anticoagulation for atrial fibrillation.

del Zoppo GJ, Eliasziw M.

N Engl J Med. 2011 Sep 8;365(10):952-3. doi: 10.1056/NEJMe1107516. Epub 2011 Aug 10. No abstract available.

PMID:
21830960
2.

A new era for anticoagulation in atrial fibrillation.

Mega JL.

N Engl J Med. 2011 Sep 15;365(11):1052-4. doi: 10.1056/NEJMe1109748. Epub 2011 Aug 27. No abstract available.

PMID:
21870977
3.

[Update on current care guidelines: atrial fibrillation].

Käypä hoito -suosituksen päivitystiivistelmä.

Duodecim. 2012;128(4):374-6. Finnish.

PMID:
22448550
4.

What are the new therapeutic alternatives to warfarin in atrial fibrillation?

Kamran SH, Muzammil SM, Kamal AK.

J Pak Med Assoc. 2013 Jan;63(1):129-30. Review. No abstract available.

PMID:
23865151
5.

New agents to prevent strokes in nonvalvular atrial fibrillation.

Putney D, Pratt C.

Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):44-6.

6.

Treatment of atrial fibrillation.

[No authors listed]

Med Lett Drugs Ther. 2014 Jul 7;56(1446):53-8. No abstract available.

PMID:
25046325
7.

New oral anticoagulant in atrial fibrillation: are they comparable?

Kalodiki E, Lewis B, Fareed J.

Int Angiol. 2012 Aug;31(4):307-9. No abstract available.

PMID:
22801395
8.

Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.

Kosar L, Jin M, Kamrul R, Schuster B.

Can Fam Physician. 2012 Aug;58(8):850-8. Review. No abstract available.

9.

Should the newer oral anticoagulants be withheld from patients with valvular AF?

Dalen JE.

Chest. 2013 Aug;144(2):369-70. doi: 10.1378/chest.13-0666. No abstract available.

PMID:
23918100
10.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
11.

Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.

Zhang S.

J Zhejiang Univ Sci B. 2012 Aug;13(8):609-15. doi: 10.1631/jzus.B1201007. Review.

12.

Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".

Stöllberger C, Finsterer J.

Thromb Haemost. 2013 Sep;110(3):496-500. doi: 10.1160/TH13-03-0246. Epub 2013 Jun 27. No abstract available.

PMID:
23803875
13.

What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

Ahrens I, Lip GY, Peter K.

Thromb Haemost. 2011 Apr;105(4):574-8. doi: 10.1160/TH10-12-0808. Epub 2011 Jan 12. No abstract available.

PMID:
21225102
14.

Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.

Skjøth F, Larsen TB, Rasmussen LH.

Thromb Haemost. 2012 Sep;108(3):405-6. doi: 10.1160/TH12-06-0438. Epub 2012 Jul 10. No abstract available.

PMID:
22782445
15.

Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".

Diener HC.

Thromb Haemost. 2013 Sep;110(3):493-5. doi: 10.1160/TH13-04-0277. Epub 2013 Jun 27. No abstract available.

PMID:
23803957
16.
17.

Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?

Harenberg J, Marx S, Wehling M.

Thromb Haemost. 2012 Sep;108(3):407-9. doi: 10.1160/TH12-07-0463. Epub 2012 Jul 26. No abstract available.

PMID:
22837027
18.

New anticoagulants.

Griffiths M, Scully C.

Br Dent J. 2012 Aug;213(3):96. doi: 10.1038/sj.bdj.2012.674. No abstract available.

PMID:
22878287
19.

Atrial fibrillation choices. Picking an anti-clotting drug.

[No authors listed]

Mayo Clin Health Lett. 2014 Jun;32(6):4-5. No abstract available.

PMID:
25029747
20.

A new era of antithrombotic therapy in patients with atrial fibrillation.

Golwala H, Dib C, Tafur A, Abu-Fadel MS.

Am J Med Sci. 2012 Aug;344(2):128-35. doi: 10.1097/MAJ.0b013e3182429b1e. Review.

PMID:
22245946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk